AS-164: A Randomized Comparison of Zotarolimus-Eluting Stents Versus Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total Occlusion: Interim Analysis of Coronary Angiography

Hun‐Jun Park(Soonchunhyang University), Sung-Ho Hur(The Catholic University of Korea Daejeon St. Mary's Hospital), Dong-Il Shin(Catholic University of Korea), Dong‐Bin Kim(St. Paul's Hospital), Yoonseok Choi(Catholic University of Korea), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Yoon‐Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Ki‐Bae Seung
The American Journal of Cardiology
April 1, 2010
10.1016/j.amjcard.2010.01.211
Cited by 0

Related Papers

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
|Circulation|2013|281